Waqoo has agreed to a tender offer from SBC Medical Group, enabling SBC to acquire a controlling interest in the company to enhance collaboration in product development and expand market presence.

Target Information

Waqoo (Ticker: 4937) is a company primarily engaged in the e-commerce sales of its own branded cosmetics. Established in 2005 originally to sell pet products, Waqoo later diversified into health supplements and cosmetics, leading to its rebranding in 2015. The company achieved a listing on the Tokyo Stock Exchange Mothers market in 2021 and subsequently transitioned to the Tokyo Stock Exchange Growth market in April 2022.

As a pioneering player in the beauty and health sector, Waqoo has cultivated a solid reputation for its product planning and development efforts, catering to a broad audience through electronic commerce platforms. With aspirations to enhance its industry presence, Waqoo is now set to become a subsidiary of SBC Medical Group in response to a tender offer.

Industry Overview in Japan

The Japanese beauty and healthcare market is highly competitive and dynamic, characterized by continuous innovation and shifting consumer preferences. In recent years, there has been a marked increase i